ABSTRACT Biotherapeutics are required to achieve high remission rates in patients with severe ulcerative colitis (UC); however, adverse effects, complex dosing regimens, administration routes, and low patient compliance limit their widespread clinical use. Given the localized nature of UC, this study aimed to develop l...
Rafaela Gazzi, T. Cremona, Reto Czekalla et al.· Advancement of science· 0 citations
Highlights What are the main findings? T-cell–specific deletion of PTPN23 causes a marked reduction in T-cells, accompanied by preferential accumulation of TCRγδ T-cells and enrichment of differentiated effector/memory T-cell subsets. Multi-omics and single-cell RNA sequencing reveal alterations in T-cell developmental...
Rocio Sanchez Alvarez, M. Determann, L. Linzmeier et al.· Cells· 0 citations
In-vitro findings demonstrate that PTPN23 overexpression resulted in reduced proliferation levels and follow-up experiments showed suppression of colorectal cancer growth and proliferation in experimental CRC models, providing a basis for future studies addressing its biological function and therapeutic relevance.
Rocio Sanchez Alvarez, C. Gottier, A. Montalban-Arques et al.· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.